Unlock instant, AI-driven research and patent intelligence for your innovation.

A tetravalent platinum complex targeting carbonic anhydrase and its preparation method and application

A technology of carbonic anhydrase and tetravalent platinum, which is applied in the direction of platinum-based organic compounds, platinum-group organic compounds, and compounds containing elements of group 8/9/10/18 of the periodic table, etc. and poor specificity to achieve the effect of reducing liver damage, simple preparation method, and broad development space

Active Publication Date: 2021-01-15
SUN YAT SEN UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is to overcome the defects and deficiencies of the above-mentioned existing chemotherapeutic drugs with relatively large toxic and side effects, poor selectivity and specificity, and provide a drug with no toxic and side effects, high stability, high selectivity and high targeting specificity. Tetravalent platinum complexes, using CAIX overexpressed on the cell membrane surface as an entry point to improve the selectivity and hypoxic toxicity of existing chemotherapy drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A tetravalent platinum complex targeting carbonic anhydrase and its preparation method and application
  • A tetravalent platinum complex targeting carbonic anhydrase and its preparation method and application
  • A tetravalent platinum complex targeting carbonic anhydrase and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Preparation of tetravalent platinum complex targeted by carbonic anhydrase in embodiment 1

[0062] 1. Experimental method

[0063] S1. Dissolve cisplatin (2.0mmol, 600.0mg) in 35.0mL of deionized water, add 12.0mL of 30% hydrogen peroxide (H 2 o 2 ), carry out redox reaction at 65°C for 5h, then react overnight at room temperature, remove H by filtration 2 o 2 , to obtain a pale yellow solid, which is cis-diamine dichlorodihydroxyplatinum (IV);

[0064] S2. Add the cis-diamine dichlorodihydroxyplatinum (IV) (333.0 mg, 1.0 mmol) obtained in step S1 into 3.0 mL of anhydrous dimethyl sulfoxide (DMSO), and add succinic anhydride under magnetic stirring (240.2mg, 2.2mmol), anhydride reaction at 25°C for 24h, after the reaction was completed, 100.0mL of water was added, the solvent was lyophilized, and the solid was washed three times with ice acetone and ice ether to obtain a white solid, namely cis-di Amine dichlorodicarboxy platinum (IV);

[0065] S3. Weigh the cis-...

Embodiment 2

[0074] Example 2 Preparation of tetravalent platinum complex targeted by carbonic anhydrase

[0075] 1. Experimental method

[0076] S1. Dissolve oxaliplatin (795.0mg, 2mmol) in 35.0mL of deionized water, add 12.0mL of 30% H2O under magnetic stirring 2 o 2 , carry out redox reaction at 70°C for 4h, then react overnight at room temperature, remove H by filtration 2 o 2 , to obtain a gray solid, which is cis-oxalic acid (trans-1,2-cyclohexanediamine) dihydroxyplatinum (II);

[0077] S2. Add cis-oxalic acid (trans-1,2-cyclohexanediamine) dihydroxyplatinum (II) (429.3 mg, 1.0 mmol) obtained in step S1 into 3.0 mL of anhydrous DMF, and add under magnetic stirring Succinic anhydride (240.2 mg, 2.4 mmol), reacted at 70°C for 48 hours, after the reaction was completed, 100.0 mL of water was added, the solvent was removed by lyophilization, and the solid was washed three times with ice acetone and ice ether to obtain a brown-gray solid, which was cis - Platinum(IV) oxalate (trans-...

Embodiment 3

[0088] Example 3 Study on the Activity of Complex 1 on Various Tumor Cell Lines

[0089] 1. Experimental method

[0090] Cytotoxicity was determined by the tetrazolium salt (MTT) colorimetric method. Cells were digested with trypsin, collected, and resuspended into a single cell suspension with culture medium, and the cell concentration was adjusted to 5 × 10 by cell counting. 4 / mL, and inoculated in a 96-well culture plate, 160 μL per well, at 37 ° C, containing 5% CO 2 After culturing in the incubator for 24 hours, drugs of different concentrations were added respectively (dosing well: add the complex 1 prepared in Example 1 above; control well: add cisplatin), and continue to incubate for 72 hours. 4 hours before the end, at Add 20 μL MTT (5 mg / mL) to each well, carefully remove the supernatant after 4 hours, add 150 μL DMSO to each well, shake at room temperature for 10 min, and measure the OD value of each well at a wavelength of 595 nm with a microplate reader.

[00...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a carbonic anhydrase (CAIX) targeted Pt (IV) complex as well as a preparation method and application thereof. The invention firstly provides the CAIX-targeted Pt (IV) complex which has the targeting characteristic of CAIX, can specifically identify tumor cells, effectively inhibit the activity of CAIX, is non-toxic to normal cells, enhances the toxicity under the conditionof anoxia, and has remarkable antitumor activity. Compared with a Pt (II) drug, the complex has the characteristics of improving tumor selectivity, reducing liver injury, reducing renal toxicity and having no toxic or side effect, and can be specifically combined with an anti-tumor target, so that the sensitivity of the platinum drug in a hypoxia environment is improved. The invention also provides a preparation method of the complex, which comprises the following steps of: mixing CAIXi and Pt (IV) - COOHx in a DMF solution containing N,N-diisopropylethylamine, and carrying out condensation reaction to obtain the complex. The preparation method is simple and low in cost. The product has a good antitumor drug application prospect and a wide development space.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, and more specifically relates to a carbonic anhydrase-targeted tetravalent platinum complex and its preparation method and application. Background technique [0002] Platinum drugs were approved by the US FDA in 1978 for the treatment of cancer drugs. Among them, cisplatin, as the first generation of platinum drugs, attracted attention because it could reduce the mortality rate of testicular cancer patients to less than 10%. Treatment of ovarian cancer, bladder cancer, lung cancer, cervical cancer and head and neck cancer. However, cisplatin has relatively large toxic and side effects, such as nephrotoxicity, ototoxicity, and neurotoxicity. With the development of platinum-based drugs, carboplatin and oxaliplatin have been approved in the international market; in addition, nedaplatin, roplatin and heptaplatin have also been approved for marketing in some regions. At present, the tox...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61P35/00
CPCA61P35/00C07F15/0093
Inventor 毛宗万周丹捷杨刚刚潘正银曹乾黄华珍
Owner SUN YAT SEN UNIV